IBD Treatments Compared in Older Patients With Crohn Disease, Ulcerative Colitis
In older patients with inflammatory bowel disease, tumor necrosis factor alpha antagonist therapy and vedolizumab were found to be comparable with regard to both safety and effectiveness.